RSSCategory: Health Policy

Why insurance companies control your medical care – analysis

Why insurance companies control your medical care – analysis

By Christy Ford Chapin, University of Maryland, Baltimore County Originally published on The Conversation It’s that time of year again. Insurance companies that participate in the Affordable Care Act’s state health exchanges are signaling that prices will rise dramatically this fall. And if insurance costs aren’t enough of a crisis, researchers are highlighting deficiencies in health care […]

October 4, 2016 | By | Reply More
Poll finds majority of Americans want restraints on drug prices

Poll finds majority of Americans want restraints on drug prices

By Jordan Rau Kaiser Health News An overwhelming majority of Americans favor government action to restrain prescription drug prices, according to a poll released Thursday. Eighty-two percent of those polled said they want Medicare to negotiate prices with the companies, which Congress does not allow. Seventy-eight percent favored limiting the amount companies can charge for […]

September 29, 2016 | By | Reply More
When drug reviewers leave the FDA, they often go to work for pharma

When drug reviewers leave the FDA, they often go to work for pharma

By Sydney Lupkin Kaiser Health News More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies, according to research published by a prominent medical journal Tuesday. Dr. Vinay Prasad, a hematologist-oncologist and assistant professor […]

September 28, 2016 | By | Reply More
Expert panel recommends expansion of services with no cost sharing for women

Expert panel recommends expansion of services with no cost sharing for women

By Michelle Andrews Kaiser Health News The list of preventive services that women can receive without paying anything out of pocket under the health law could grow if proposed recommendations by a group of mostly medical providers are adopted by federal officials later this year. The draft recommendations, which are subject to public comment until Sept. 30,  build upon […]

September 27, 2016 | By | Reply More
Doctor confesses: I lied to protect colleague in malpractice suit

Doctor confesses: I lied to protect colleague in malpractice suit

By Marshall Allen ProPublica Almost two decades ago Dr. Lars Aanning sat on the witness stand in a medical malpractice trial and faced a dilemma. The South Dakota surgeon had been called to vouch for the expertise of one of his partners whose patient had suffered a stroke and permanent disability after an operation. The […]

September 26, 2016 | By | Reply More
EpiPen not just for kids: Medicare spending for the drug up 1,100 percent

EpiPen not just for kids: Medicare spending for the drug up 1,100 percent

By Julie Appleby and Mary Agnes Carey Kaiser Health News Even as the cost of EpiPens dramatically rose, so too did the number of prescriptions written for patients in Medicare, sending spending by the program skyrocketing nearly 1,100 percent from 2007 to 2014, a new report shows. During the same period, the total number of […]

September 24, 2016 | By | Reply More
How can we get pharma companies to do more for global health? Try ranking them

How can we get pharma companies to do more for global health? Try ranking them

By Nicole Hassoun, Binghamton University, State University of New York From TheConversation.org The World Health Organization reports that a third of the world’s population cannot access important medicines for some of the world’s most devastating diseases, like malaria and tuberculosis. There are many reasons these drugs are out of reach of so many people, but the […]

September 21, 2016 | By | Reply More
FDA approves first drug to treat rare form of muscular dystrophy

FDA approves first drug to treat rare form of muscular dystrophy

By Liz Szabo Kaiser Health News The Food and Drug Administration Monday approved the first drug to treat Duchenne muscular dystrophy, a rare and lethal muscle weakening disorder that affects about 15,000 Americans. The FDA’s approval of the drug, Exondys 51, also known generically as eteplirsen, came over the objections of its own advisory committee, […]

September 20, 2016 | By | Reply More
Studies link cancer patient’s survival time to insurance status

Studies link cancer patient’s survival time to insurance status

By Michelle Andrews Kaiser Health News Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies. In one study, researchers examined data from more than 13,600 adult patients who had glioblastoma multiforme, the most common type […]

September 18, 2016 | By | Reply More
Clinical trial results must be published within 12 months, NIH says

Clinical trial results must be published within 12 months, NIH says

[embedyt] http://www.youtube.com/watch?v=cPF7gGbCuWQ[/embedyt] In an effort to make information about clinical trials widely available to the public, the U.S. Department of Health and Human Services today issued a final rule that specifies requirements for registering certain clinical trials and submitting summary results information to ClinicalTrials.gov. The new rule expands the legal requirements for submitting registration and […]

September 17, 2016 | By | Reply More